Advanced Materials · 2016 · 119 citations · 39 references
Life SciencesImmunologyOncologyCancer ImmunologyDrug DeliveryImmunotherapyCancer ImmunotherapyCancer NanomedicineNanocarriers For TherapeuticsNanomedicineNanoparticle Delivery SystemsNucleic Acid DeliveryCancer Immunotherapy NanoparticlesCancer NanotherapyImmunostimulatory AgentsImmunostimulatory NanoparticlesMultifunctional NanoplatformsMurine ModelsNanodiamondsNanoparticle-based Immunotherapy
The use of functional nanodiamonds (fNDs) to deliver CpG oligonucleotides (ODNs) for sustained immunostimulation is reported. It is demonstrated that monotherapy using this immunostimulatory agent significantly suppresses the tumor growth in two murine tumor models. This fND-based nanoagent opens new opportunities for immunotherapy, as well as clinical applications of various types of therapeutic nucleic acids. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
39
A Toll-like receptor recognizes bacterial DNA
Hiroaki Hemmi, Osamu Takeuchi, Taro Kawai et al. · Nature · 2000 · 6.4K citations
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Eicke Latz, Annett Schoenemeyer, Alberto Visintin et al. · Nature Immunology · 2004 · 1.3K citations
Binding of blood proteins to carbon nanotubes reduces cytotoxicity
Cuicui Ge, Jiangfeng Du, Lina Zhao et al. · Proceedings of the National Academy of Sciences · 2011 · 937 citations · Full text